跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VYVGART - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VYVGART
Authorized
STANDARD
VYVGART
ARGENX BV
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9b5060ebb402b9c2
Company
ARGENX BV
Type
Standard
Approval Details
Approval Id
9b5060ebb402b9c2
Drug Approval Canada Name
VYVGART
Product Name
VYVGART
Status
Marketed
Status Date
2023-11-06
Original Market Date
2023-11-06
Din
02541599
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D , Prescription
Ahfs
90:28.00
Atc Original
L04AA58 EFGARTIGIMOD ALFA
Atc Name
l 04 aa 58
Aig Number
0165001001
Company Name
ARGENX BV
Company Address
Industriepark Zwijnaarde 7, Zwijnaarde, --, Belgium, 9052
Company Detail Path
/organization/argenx-bv
Company Information
Pharmaceutical Company Name
ARGENX BV
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Active Ingredients
EFGARTIGIMOD ALFA
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9b5060ebb402b9c2
Type
Standard
Back to Health Canada Approvals